1-12 of 12
Heinz Kirchen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of a Safety Run-in Cohort from Niveau, a Phase 3 Study for Patients with Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivolumab in Combination with Gemcitabine, Oxaliplatin (GemOx) Plus Rituximab (R) in Case of B-Cell Lymphoma

Gerhard Held, MD, Corinne Haioun, MD PhD, Roch Houot, MD PhD, Philippe Gaulard, MD PhD, Thierry Molina, Andreas Rosenwald, MD, Marc André, Joerg Hoffmann, MD, Martin Dreyling, MD, Olivier Casasnovas, MD, Herve Maisonneuve, MD, Herve Tilly, MD PhD, Thomas Illmer, Stephanie Mayer, MD, Heinz Kirchen, MD, Paul La Rosée, MD, Markus Loeffler, MD, Marita Ziepert, PhD, Bettina Altmann, PhD, Viola Poeschel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4085.
https://doi.org/10.1182/blood-2019-129347
Published: 2019
Journal Articles

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Uwe Platzbecker, MD, Eva Lengfelder, MD, Kerstin Schäfer-Eckart, MD, Katharina S Götze, MD, Michael Heuser, MD, Felicitas Thol, MD, Helmut R. Salih, MD, Mathias Hänel, MD, Karsten Spiekermann, Sonja Martin, MD, Sigrid Machherndl-Spandl, MD, Volker Kunzmann, MD, Andreas Jakob, MD, Hans-Joachim Tischler, MD, Dirk Niemann, MD, Joerg Mezger, MD, Tilmann Bochtler, MD, Stefan Krause, MD, Maike de Wit, MD, Claudia D. Baldus, MD, Richard Greil, MD, Jochen Greiner, Mark Ringhoffer, MD, Markus Radsak, MD, Mohammed Amen Wattad, MD, Wolff Schmiegel, MD, Elisabeth Koller, MD, Frank Heits, MD, Albrecht Reichle, MD, Stephan Kremers, MD, Andreas Hochhaus, MD, Nadezda Basara, MD, Dominik Wolf, MD, Martin Goerner, MD, Markus Schaich, MD, Harald Biersack, MD, Heinz Kirchen, MD, Thomas Kubin, MD, Gregor Aschauer, MD, Tanja Hesse, MD, Hartmut Link, MD PhD, Heinz Duerk, MDPhD, Dorit Kuerschner, MD, Walter Fiedler, MD, Bernd Hertenstein, MD, Martin Puttrich, Michael Kramer, M.Sc., Michaela Sauer, Wolfgang Hiddemann, Ulrich Duehrsen, MD, Hubert Serve, Christian Thiede, MD, Arnold Ganser, MD, Tim H. Brummendorf, MD, Konstanze Dohner, MD, Martin Bornhäuser, MD, Richard F. Schlenk, MD, Christoph Rollig, MD MSC, Hartmut Döhner, MD, Gerhard Ehninger, Peter Paschka, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2618.
https://doi.org/10.1182/blood.V130.Suppl_1.2618.2618
Published: 2017
Journal Articles

Excellent Outcome of Elderly Patients with Favourable-Prognosis DLBCL Treated with 4 Cycles CHOP/Chlip-14 Plus 8 Applications of Rituximab and a PET-Based Intensification Strategy That Includes Involved-Site Radiotherapy (IS-RT): Results of the First 120 Patients of the OPTIMAL>60 Trial of the Dshnhl

Michael Pfreundschuh, MD, Niels Murawski, MD, Konstantinos Christofyllakis, Bettina Altmann, Marita Ziepert, PhD, Mathias Haenel, MD, Andreas Viardot, MD, Andreas Neubauer, MD, Gerhard Held, MD, Lorenz Truemper, Christian Schmidt, MD, Lothar Kanz, Kai Huebel, MD, Norbert Schmitz, MD, Tobias Heintges, MD, Heinz Kirchen, MD, Günther Schneider, MD, Christian Ruebe, MD, Christian Berdel, MD, Dirk Hellwig, MD, Jirka Grosse, MD, Viola Poeschel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1549.
https://doi.org/10.1182/blood.V130.Suppl_1.1549.1549
Published: 2017
Journal Articles

Clinical Relevance of Alternatively Spliced Isoform AML1-ETO9a in Adult Patients with t(8;21)(q22;q22.1) Acute Myeloid Leukemia (AML): A Study of the German-Austrian AML Study Group (AMLSG)

Mridul Agrawal, MDMSc, Andrea Corbacioglu, PhD, Daniela Weber, MSc, Verena I. Gaidzik, MD, Marianne Habdank, Nikolaus Jahn, MD, Thomas Michael Schroeder, MD, Thomas Kindler, MD, Mohammed Amen Wattad, MD, Michael Lübbert, Walter Fiedler, MD, Katharina S. Götze, MD, Mark Ringhoffer, MD, Jan Schleicher, MD, Elisabeth Lange, MD, Michael Pfreundschuh, MD, Martin Griesshammer, Richard Greil, MD, Heinz Kirchen, MD, Elisabeth Koller, MD, Felicitas Thol, MD, Jurgen Krauter, MD, Richard F. Schlenk, MD, Michael Heuser, MD, Arnold Ganser, MD, Lars Bullinger, MD, Peter Paschka, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2685.
https://doi.org/10.1182/blood.V130.Suppl_1.2685.2685
Published: 2017
Journal Articles

Minimal Residual Disease Monitoring in Acute Myeloid Leukemia (AML) with Translocation t(8;21)(q22;q22): Results of the AML Study Group (AMLSG)

Mridul Agrawal, MD, Andrea Corbacioglu, PhD, Peter Paschka, MD, Daniela Weber, Verena I. Gaidzik, MD, Nikolaus Jahn, MD, Andrea Kündgen, MD, Thomas Kindler, MD, Mohammad Amen Wattad, MD, Michael Lübbert, MD, Walter Fiedler, MD, Katharina Götze, MD, Mark Ringhoffer, MD, Jan Schleicher, MD, Elisabeth Lange, MD, Gerhard Held, MD, Martin Griesshammer, MD, Richard Greil, MD, Heinz Kirchen, MD, Elisabeth Koller, MD, Felicitas Thol, MD, Jürgen Krauter, MD, Michael Heuser, MD, Arnold Ganser, MD, Lars Bullinger, MD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2016) 128 (22): 1207.
https://doi.org/10.1182/blood.V128.22.1207.1207
Published: 2016
Journal Articles

Condensed Versus Standard Schedule of High-Dose Cytarabine Consolidation Therapy with Pegfilgrastim Growth Factor Support in Acute Myeloid Leukemia

Sonia Jaramillo, MD, Axel Benner, Jurgen Krauter, Hans Martin, MD, Thomas Kindler, MD, Martin Bentz, MD, Helmut R. Salih, MD, Gerhard Held, MD, Caus-Henning Köhne, MD, Katharina Götze, Michael Lübbert, MD, Andrea Kündgen, MD, Peter Brossart, MD, Mohammad Amen Wattad, MD, Hans-Juergen Salwender, MD, Bernd Hertenstein, MD, David Nachbaur, MD, Gerald Wulf, MD, Heinz A. Horst, MD PhD, Heinz Kirchen, MD, Walter Fiedler, MD, Aruna Raghavachar, MD, Gudrun Russ, MD, Stephan Kremers, Elisabeth Koller, MD, Volker Runde, MD, Gerhard Heil, Daniela Weber, Brigitte Schlegelberger, Prof, MD, Konstanze Döhner, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2016) 128 (22): 337.
https://doi.org/10.1182/blood.V128.22.337.337
Published: 2016
Journal Articles

Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3 -ITD: Interim-Analyses of the AMLSG 16-10 Trial

Richard F. Schlenk, MD, Walter Fiedler, MD, Helmut R. Salih, MD, Gerald Wulf, MD, Felicitas Thol, MD, Andrea Kündgen, MD, Thomas Kindler, MD, Hans-Juergen Salwender, MD, Michael Lübbert, MD, Peter Brossart, MD, Jörg Westermann, MD Prof, Doris Kraemer, MD, Katharina Goetze, MD, Heinz-August Horst, MD PhD, Jürgen Krauter, MD, Michael Girschikofsky, MD, Mark Ringhoffer, MD, Thomas Südhoff, MD, Gerhard Held, MD, Hartmut H. Kirchner, MD, Wolff Schmiegel, MD, Richard Greil, MD, Martin Griesshammer, MD, Elisabeth Lange, MD, Uwe Martens, MD, Bernd Hertenstein, MD, Maike de Wit, Elisabeth Koller, MD, Andreas L. Petzer, MD, Tanja Hesse, MD, Volker Runde, MD, Peter Reimer, MD, Beate S. Schultheis, MD, Heinz Kirchen, MD, Frank Griesinger, MD, Holger Hebart, MD, Gerhard Heil, Stephan Kremers, David Nachbaur, MD, Nadezda Basara, MD, Carsten Schwänen, Daniel Schöndube, MD, Jochen Greiner, Anja Münnich, Daniela Weber, Verena I. Gaidzik, MD, Maria-Veronica Teleanu, MD, Peter Paschka, MD, Frauke Theis, Axel Benner, Michael Heuser, MD, Konstanze Döhner, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2016) 128 (22): 449.
https://doi.org/10.1182/blood.V128.22.449.449
Published: 2016
Journal Articles

Prospective Phase III Trial Of Valproic Acid (VPA) In Combination With All-Trans Retinoic Acid (ATRA) and Intensive Induction Therapy For AML In Older Patients: Final and Molecular Subset Analyses Of The AMLSG 06-04 Study

Michela Giulia Tassara, MD, Konstanze Döhner, MD, Peter Brossart, MD, Gerhard Held, Katharina Goetze, MD, Heinz-August Horst, MD, Mark Ringhoffer, MD, Claus-Henning Kohne, MD, Stephan Kremers, MD, Aruna Raghavachar, MD, Gerald Wulf, MD, Heinz Kirchen, MD, David Nachbaur, MD, Hans-Günter Derigs, M.D., Mohammed Wattad, MD, Elisabeth Koller, MD, Wolfram Brugger, MD, Axel C. Matzdorff, MD, PhD, Richard Greil, MD, Gerhard Heil, MD, Daniela Späth, MSc, Peter Paschka, MD, Verena I. Gaidzik, MD, Martin Göttlicher, M.D., Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 3927.
https://doi.org/10.1182/blood.V122.21.3927.3927
Published: 2013
Journal Articles

Impact Of The Pretreatment Characteristics As Well As Cyto- and Molecular-Genetic Profile On Outcome After Relapse In Acute Myeloid Leukemia

Richard F. Schlenk, MD, Peter Frech, Sabine Kayser, MD, Daniela Späth, MSc, Peter Brossart, MD, Heinz-August Horst, MD, Doris M Kraemer, M.D., Gerhard Held, Mark Ringhoffer, MD, Alexander Burchardt, M.D., Andrea Kündgen, M.D., Katharina Goetze, MD, David Nachbaur, MD, Thomas Kindler, MD, Michael Lübbert, MD, Helmut R. Salih, MD, Hans Salwender, MD, Gerald Wulf, MD, Elisabeth Koller, MD, Mohammed Wattad, MD, Walter Fiedler, MD, Stephan Kremers, MD, Heinz Kirchen, MD, Bernd Hertenstein, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Michael Heuser, MD, Felicitas Thol, MD, Arnold Ganser, MD, Konstanze Döhner, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 830.
https://doi.org/10.1182/blood.V122.21.830.830
Published: 2013
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct to High-Dose Cytarabine-Based Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of AMLSG 05-04 Trial.

Richard F. Schlenk, MD, Konstanze Döhner, MD, Jürgen Krauter, MD, Daniela Späth, Francesco de Valle, MD, Björn Heydrich, MD, Heinz A. Horst, MD, Ingo Schmidt-Wolf, MD, Mathias Rummel, MD, Katharina Götze, MD, Elisabeth Koller, MD, Andreas Petzer, MD, Hans G. Mergenthaler, MD, Hans Salwender, MD, Walter Fiedler, MD, Heinz Kirchen, MD, Detlef Haase, MD, Stefan Krämers, MD, Matthias Theobald, MD, Axel C. Matzdorff, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2007) 110 (11): 1837.
https://doi.org/10.1182/blood.V110.11.1837.1837
Published: 2007
Journal Articles

The Genotype NPM1mut/FLT3-ITDneg Is a Highly Significant Predictive Factor for Response to Therapy with All-Trans Retinoic Acid in Acute Myeloid Leukemia - Results from AMLSG Trial AML HD98B.

Richard F. Schlenk, MD, Konstanze Döhner, MD, Michael Kneba, MD, Francesco del Valle, MD, Frank Hartmann, MD, Heinz Kirchen, MD, Elisabeth Koller, MD, Katharina Götze, MD, Jörg Th. Fischer, MD, Marianne Habdank, Daniela Späth, Silja Groner, Andrea Corbacioglu, Axel Benner, MSC, Stefan Fröhling, Hartmut Döhner
Journal: Blood
Blood (2007) 110 (11): 297.
https://doi.org/10.1182/blood.V110.11.297.297
Published: 2007
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Richard F. Schlenk, MD, Konstanze Doehner, MD, Martina Kerz, Frank Hartmann, MD, Francesco del Valle, MD, Axel Glasmacher, MD, Hans Pralle, MD, Katharina Goetze, MD, Elisabeth Koller, MD, Guenther Gastl, MD, Hans G. Mergenthaler, MD, Hans Salwender, MD, Heinz Kirchen, MD, Detlef Haase, MD, Stephan Kremers, MD, Christoph Nerl, MD, Matthias Theobald, MD, Axel C. Matzdorff, MD, Arnold Ganser, MD, Hartmut Doehner, MD, for the German-Austrian, AML Study Group (AMLSG)
Journal: Blood
Blood (2005) 106 (11): 1849.
https://doi.org/10.1182/blood.V106.11.1849.1849
Published: 2005